Mots clés
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Obstetrics and Gynaecology CanadaRÉFÉRENCES
- 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum.Thyroid. 2017; 27: 315-389
- Subclinical hypothyroidism in the infertile female population: a guideline.Fertil Steril. 2015; 104: 545-553
- Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy.N Engl J Med. 2017; 376: 815-825
- Effect of levothyroxine on miscarriage among women with normal thyroid function and thyroid autoimmunity undergoing in vitro fertilization and embryo transfer: a randomized clinical trial.JAMA. 2017; 318: 2190-2198
- Levothyroxine in women with thyroid peroxidase antibodies before conception.N Engl J Med. 2019; 380: 1316-1325
- Impact of levothyroxine therapy on obstetric, neonatal and childhood outcomes in women with subclinical hypothyroidism diagnosed in pregnancy: a systematic review and meta-analysis of randomised controlled trials.BMJ Open. 2018; 8e022837
- Antenatal thyroid screening and childhood cognitive function.N Engl J Med. 2012; 366: 493-501
- Variation in thyroid function in subclinical hypothyroidism: importance of clinical follow-up and therapy.Eur J Endocrinol. 2011; 164: 317-323
- Thyroid dysfunction and autoimmunity in infertile women.Thyroid. 2002; 12: 997-1001
- Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome.Arch Gynecol Obstet. 2012; 285: 853-856
- Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis.Am J Reprod Immunol. 2011; 66: 108-114
- Elevated antithyroid peroxidase antibodies indicating Hashimoto's thyroiditis are associated with the treatment response in infertile women with polycystic ovary syndrome.Fertil Steril. 2010; 94: 2895-2897
- Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence.BMJ. 2011; 342: d2616
- Thyroid function test abnormalities during pregnancy.JAMA. 2019; 322: 617-619
- Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth: a systematic review and meta-analysis.JAMA. 2019; 322: 632-641
- The impact of thyroid function on intrauterine insemination outcome—a retrospective analysis.Reprod Biol Endocrinol. 2014; 12: 28
- Preconceptional thyroid-stimulating hormone levels and outcomes of intrauterine insemination among euthyroid infertile women.Fertil Steril. 2015; 103 (258–63 e1)
- Correlation of thyroid stimulating hormone (TSH) level with pregnancy outcome in women undergoing in vitro fertilization.Am J Obstet Gynecol. 2006; 194 (discussion 74–5): 1668-1674
- Thyroid function in infertile patients undergoing assisted reproduction.Am J Reprod Immunol. 2013; 70: 336-341
- Effect of levothyroxine treatment on in vitro fertilization and pregnancy outcome in infertile women with subclinical hypothyroidism undergoing in vitro fertilization/intracytoplasmic sperm injection.Fertil Steril. 2011; 95: 1650-1654
- Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study.Hum Reprod. 2005; 20: 1529-1533
- Preconception steroid treatment in infertile women with antithyroid autoimmunity undergoing ovarian stimulation and intrauterine insemination: a double-blind, randomized, prospective cohort study.Clin Ther. 2010; 32: 2415-2421
- In women with thyroid autoimmunity, does low-dose prednisolone administration, compared with no adjuvant therapy, improve in vitro fertilization clinical results?.J Obstet Gynaecol Res. 2015; 41: 722-728
- Potential significance of physiological and pharmacological glucocorticoids in early pregnancy.Hum Reprod Update. 2008; 14: 497-517
- The clinical use of corticosteroids in pregnancy.Hum Reprod Update. 2016; 22: 240-259
Article info
Publication history
Footnotes
Le présent document correspond au consensus clinique et scientifique en vigueur au moment de sa publication et est sujet à changement. Les renseignements qu'il contient ne doivent pas être considérés comme les seuls traitements ou les seules interventions applicables. Les établissements locaux peuvent modifier les recommandations. La SOGC conseille toutefois aux établissements de bien documenter de telles modifications.
Consentement éclairé : Chaque personne a le droit et la responsabilité de prendre des décisions éclairées relativement aux soins qu'elle reçoit avec ses fournisseurs de soins de santé. Pour aider les patientes à faire un choix éclairé, la SOGC recommande que les fournisseurs de soins de santé offrent aux patientes un soutien et des renseignements fondés sur des données probantes en veillant à les adapter à leur culture et à leurs besoins.
Langue et inclusion : Le présent document utilise un langage genré afin de favoriser le langage clair, mais il se veut inclusif de chaque personne, y compris les personnes qui ne s'identifient pas comme femme. La SOGC reconnaît et respecte les droits de chaque personne à qui le présent contenu pourrait s'appliquer, notamment les personnes transgenres, non binaires ou intersexes. La SOGC encourage les fournisseurs de soins de santé à s'engager dans une conversation respectueuse avec chaque patiente et patient relativement à son identité de genre et au pronom de genre de son choix, ainsi qu’à appliquer les présentes directives comme il convient pour répondre aux besoins de chaque personne.
Droit d'auteur : Le contenu du présent document ne peut être reproduit d'aucune manière, en tout ou en partie, sans l'autorisation écrite préalable de l’éditeur.
Identification
Copyright
ScienceDirect
Access this article on ScienceDirectLinked Article
- Committee Opinion No. 407: Thyroid Disease and InfertilityJournal of Obstetrics and Gynaecology Canada Vol. 42Issue 10
- PreviewIn 2017, the American Thyroid Association (ATA) published guidelines for the diagnosis and management of thyroid disease during pregnancy,1 including 3 pages devoted to the impact of thyroid disease on infertility and assisted reproduction. The American Society for Reproductive Medicine (ASRM) also published a guideline on subclinical hypothyroidism and infertility in 2015.2 However, neither the ATA nor the ASRM recommendations have high-quality evidence supporting them. To date, the American College of Obstetricians and Gynecologists and Society of Obstetricians and Gynaecologists of Canada have not published their own recommendations on the screening and management of thyroid disease in women with infertility or undergoing assisted reproduction.
- Full-Text
- Preview
